A Pilot Intervention To Improve Injection Practices In The Informal Private Sector in Karachi, Pakistan Mubina Agboatwalla (1) Yvan Hutin (2) Steve Luby.

Slides:



Advertisements
Similar presentations
TREATMENT DATA INDICATORS IN THE UNODC DATA COLLECTION SYSTEM.
Advertisements

Needle and syringe programmes Implementing NICE guidance 2009 NICE public health guidance 18.
Yudatiningsih I.1,Sunartono H.1,SuryawatiS.2
Prevention of Sepsis Among Neonates Admitted to Intensive Care Units through Promotion of Infection Control Safe Injection Global Network Meeting in Cambodia,
Unit 1. Introduction TB Infection Control Training for Managers at the National and Subnational Levels.
Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWUD in London.
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
CBIA-PREGNANCY TO IMPROVE SKILLS OF PREGNANT MOTHERS IN SELECTING OTC COMMON COLD PREPARATION.
ECONOMIC ASSESSMENT OF IMPLEMENTATION TREATMENT GUIDELINES OF HYPERTENSION IN OUT-PATIENT PRACTICE Kulmagambetov IR Karaganda State Medical Academy, Kazakhstan.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
Injection Practices in Mongolia Results and Outcomes of the Rapid Assessment of Injection Practices Dr G. Soyolgerel Dr G. Soyolgerel Ministry of Health.
© Aahung 2004 Millennium Development Goals Expanding the Agenda:
Community Planning Training 1-1. Community Plan Implementation Training 1- Community Planning Training 1-3.
Plan of Action to improve injection Safety Within the EPI.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
SIGN Rapid Assessment Survey Northern Areas, Pakistan Lubna Samad, MRCS, FCPS Pediatric Surgeon National Institute of Child Health.
Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.
EVALUATION OF A SAFE INJECTION PROJECT IN UZBEKISTAN Dr. Erkin I. Musabaev Institute of Postgraduate Medical Education, Tashkent Uzbekistan Health Ministry.
INRUD International Network for Rational Use of Drugs.
EVOLVING PUBLIC HEALTH AND HEALTH CARE LANDSCAPE AND OPPORTUNITIES FOR CANCER COMMUNICATION NCI Health Communication and Informatics Research Branch CPCRN.
Nursing Care Makes A Difference The Application of Omaha Documentation System on Clients with Mental Illness.
Impact of a public education program on promoting rational use of medicines: a household survey in south district of Tehran, Darbooy SH, Hosseini.
ABSTRACT SELECTING NATURAL INSULIN IMPROVES ACCESS TO COST-EFFECTIVE THERAPY OF DIABETIC PATIENTS IN THE PUBLIC SECTOR OF DAR ES SALAAM, TANZANIA Title:
1 Dr.I.A.Joshua 2 Dr JG Makama 3 Dr A Oyemecho 1 Department of Community/ 2 Department of Surgery Kaduna State University, Kaduna, Nigeria 3 Department.
Program Collaboration and Service Integration: An NCHHSTP Green paper Kevin Fenton, M.D., Ph.D., F.F.P.H. Director National Center for HIV/AIDS, Viral.
JCAHO UPDATE June The Bureau of Primary Health Care is continuing to encourage Community Health Centers to be JCAHO accredited. JCAHO’s new focus.
Safe and Appropriate Use of Injection Activities of WHO’s Department of Blood Safety and Clinical Technology (BCT) Yvan Hutin Annual SIGN Meeting New Delhi.
IMPROVING DIABETES MANAGEMENT IN PRIMARY CARE
The policy development for introducing of the oral fluid based rapid HIV test kit in Thailand Writers in the 2009 Write Workshop (WHO Bulletin)
Safe Immunization Practices and Prevention of Hepatitis B and C Susan Mackay Behaviour Change Project Safe Injection Global Network.
Conclusions of the meeting and closing remarks. Chronology 1981Hepatitis B vaccine becomes available 1991World Health Assembly resolution call for the.
Increasing Access to Injection Equipment in Burkina Faso: When Essential Drugs Programmes Improve Injection Safety Sophie Logez Phamaciens Sans Frontières.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
1 Findings from Recent Consumer and Health-Care Provider Surveys Adelphi Research by Design supported by sanofi pasteur David R. Johnson, MD, MPHNVAC Meeting.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
Summary Over all services Some providers and clients were not aware of adverse effects of contraceptives and the possibility of sex transmitted diseases.
Abstract Impact of the Essential Drugs Programme at the Primary Health Care Level in South Africa Hela M, Zeeman H, Department of Health South Africa;
Public Perceptions about Injections and Private Sector Injection Practices in Central Nepal Mahesh Bhattarai and Scott Wittet.
PLACE Method Priorities for Local AIDS Control Efforts 1 1 MEASURE Evaluation, A Manual for implementing the PLACE Method.
CAMBODIA EXPERIENCE ON MTP TO REDUCE INAPPROPRIATE MEDICINE USE IN HOSPITALS Sok Srun & Chroeng Sokhan Ministry of Health, Kingdom of Cambodia.
Injection practices among medical practitioners working at private clinics in Karachi. Shair Muhammad Hazara BSc N, MSBE Nursing Instructor College of.
Water interventions generally described positive health impacts, but there was insufficient data on some types of interventions to draw strong conclusions.
Introduction.
Older People’s Services The Single Assessment Process.
Authors: Lates JA, Shiyandja NN Funding Institution: Ministry of Health and Social Services, Namibia Title: Third National Survey on the Use of Drugs in.
The Dilemma of Diclofenac Injection for the Iranian Health System Authors: Shalviri G, Cheraghali M, Gholami K, Kamali E, Daryabari N Institution: Ministry.
A COMPARISON OF PRESCRIBING PRACTICES BETWEEN PUBLIC AND PRIVATE SECTOR PHYSICIANS IN UGANDA Obua C, Ogwal-Okeng JW, WaakoP, Aupont O, Ross-Degnan D International.
Estimating the Global Burden of HCV Infections Associated with Unsafe Health Care Injections Anja Hauri 1, Gregory Armstrong, 2 Yvan Hutin 1 1. WHO Headquarters,
DOES DRUG USE EVALUATION (DUE) REQUIRED BY NATIONAL POLICY IMPROVE USE OF MEDICINES?
REDUCING ANTIBIOTIC OVERUSE for ARIs with SMALL- GROUP EDUCATIONAL INTERVENTION Munawaroh S 1, Sunartono H 2, Suryawati S 3 1 INRUD Yogya/Indonesia; 2.
Documenting (Driving) Progress in Immunization Injection Safety Philippe Duclos, WHO Presented at the SIGN annual meeting, Cairo, Egypt, Oct th,
SMALL GROUP DISCUSSION AMONG PARAMEDICS AT HEALTH CENTER LEVEL TO IMPROVE ADHERENCE TO STANDARD TREATMENT GUIDELINES OF ACUTE RESPIRATORY TRACT INFECTIONS.
Does Drug Use Evaluation Required by National Policy Improve Use of Medicines? Akaleephan C*, Muenpa R**, Sittitanyakit B***, Treesak C #, Cheawchanwattana.
Putting Patients at the Centre of Care What can my Community Pharmacist do for me? Dr Tarlochan Gill Chairman, Kent & Medway Pharmacy Local Professional.
From evidence to commitment to action: implementing HIV prevention measures in prisons in Ukraine XVI International AIDS Conference Toronto, 15 August.
Abstract Problem Statement: As in many former socialist economies, anecdotal reports suggested that injections were overused to administer medications.
Customers health literacy on health check-up services and primary health care providers attitudes Dulamsuren Samdan, MD,MPH,PhD President, “New Public.
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
CONCLUSIONS New Jersey’s Emergency Department HIV testing sites report higher seroprevalence than non-ED testing sites. Since University Hospital began.
Thematic Priorities for ATF Applications Presentation by Secretariat of Council for the AIDS Trust Fund in Briefing Session on 27 July
Logez S, Hutin Y, Somda P, Thualt J, Holloway K
Believed discrimination occurred because of their:
SUNARTONO HEAD OF SLEMAN DISTRICT HEALTH OFFICE, INDONESIA
International Conference on Improving Use of Medicines
Impact of a public education program on promoting rational use of medicines:
Antiretroviral therapy coverage in sub-Saharan Africa,
Kandeke C, Chibuta C, Banda D
Key Affected Populations
Toktobaeva B, Karymbaeva S Drug Information Centre Kyrgyzstan
Importance of Data Quality for National HIV Prevention Program Monitoring and Evaluation Presented by: Guoshen Wang, MS Shubha Rao, MPH; Hui Zhao, MS;
Presentation transcript:

A Pilot Intervention To Improve Injection Practices In The Informal Private Sector in Karachi, Pakistan Mubina Agboatwalla (1) Yvan Hutin (2) Steve Luby (3) Asim Mussarrat (1) Asif Ahmed (1) H 1. Health Oriented Preventive Education (HOPE), Pakistan. 2. World Health Organization, Geneva, Switzerland. 3. Center for Disease Control (CDC), Atlanta.

Problem Statement: Health Care Providers in Pakistan practicing as General Practitioners (GPs) over prescribe injections and reuse syringes commonly. Since 80% of the general population visits these GPs, they contribute significantly to poor injection practices in Pakistan. Objectives: We conducted a pilot intervention among GPs in the informal private sector in a densely populated part of Karachi with the objective of reducing injection overuse and improving injection practices. Study Design: For this 12 months intervention we assigned 20 GP’s to an intervention and selected 20 others as a control group. An initial survey assessed baseline knowledge and practices using qualitative and quantitative methods. The intervention consisted in (1) Interactive Group Discussions (IGDs) between patients and GP’s on the topic of the use of injections to treat common ailments (using methods proposed by the International Network for the Rational Use of Drugs [INRUD] in Indonesia) and (2) Health education using pamphlets and posters. Exit interviews monitored injection use and injection safety before and after the intervention in both groups. Results: Pre-Intervention information indicated that the proportion of visits followed by an injection was 88.3% among patients in the control group and 84.4% among patients in the intervention group. Following intervention this proportion remained stable (87.3%) in the control group but decreased to 51% in the intervention group (P<0.05). At baseline, 91.9% patients in the intervention and 85% in the control group were given an injection using a new single use syringe. Following the intervention, a newly packed syringe was used for 64.7% patients in the control group as opposed to 92% in the intervention group. After the intervention, 89% patients in the intervention group mentioned that the packed syringe was opened in front of them as compared to 55.6% in the control group (P<0.05) Conclusion: The combination of IGD and Health education was effective in decreasing injection overuse and achieving safer practices in the informal private sector of Karachi, Pakistan. Other interventions, including the introduction of syringes with re-use prevention feature, need to be evaluated so that injection practices can be further improved in this setting. Abstract

Project Background  In Pakistan poor injection practices are common.  Reuse of syringes is common amongst Health Care Providers (HCPs) practicing in the private sector.  In 1993 a community based study in Hafizabad found the prevalence of HCV antibody to be 6.5%. These patients had received more than 10 injections per year in the last 10 years.  Prescribers believe that patients prefer injections.  Patients feel HCPs over prescribe injections.  Patient prescriber Interactive Group Discussions (IGDs) can help in clarifying this misunderstanding and reduce injection over use.

Objectives  Reduce injection overuse and improve injection practices in the informal sector of Karachi  Identify intervention strategies that could be scaled up nationally for the safe and appropriate use of injections in the informal sector in Pakistan

Methodology  A 12 month intervention study.  Middle to lower socio-economic areas, with congested buildings.  Intervention and control areas at a distance of 5 km from each other.  HCPs operating clinics in congested lanes in strong competition with one another.  At Baseline 21 GP’s and 4 Quacks enrolled in Intervention Group. In Control Group 17 GP’s and 3 Quacks enrolled.  During study 3 GP’s and 2 Quacks dropped out from the intervention group.  Baseline information collected from intervention and control groups.  Exit interviews conducted on every fourth patient leaving the HCPs clinic, monitoring injection use and safety.  Intervention conducted over a period of 6 Months.  Interactive Group Discussions (IGDs) between patients and HCPs using methods proposed by International Network for Rational Use of Drugs (INRUD), Indonesia.  Health education using IEC Material including patient booklets, doctors booklets, posters and Focus Group Discussions.  Post Intervention survey of patients after 6 months of intervention.

Previous Visit (%) Current Visit (%) Intervention Group ( n = 500 ) 76.6%84.0% Control Group ( n = 400 ) 83.8%88.0% 93-98% patients said the doctor advised the injection Injection Therapy During Visit to HCP (Baseline Data)

Injection Therapy During Present Visit 36%

Whether Syringe was New or Packed

Patients Perception of Advantages and Disadvantages of Injections Advantages Before AdvocacyAfter Advocacy InterventionControlInterventionControl Early recovery91.00%97.50%74.4%96.25% Temporary recovery1.00%0.00%1.4%0.25% Anxiety Reduced4.20%0.75%4.4%0.0% Rapidly effective2.60%1.00%3.4%2.5% Don’t know4.20%2.50%16.6%13.25% Disadvantages Before AdvocacyAfter Advocacy InterventionControlInterventionControl Pain3.20%1.75%8.00%5.50% Adverse Reaction23.60%24.25%15.20%22.80% Swelling13.00%10.00%24.80%18.50% Abscess8.60%11.25%13.80%10.80% Fever6.20%3.25%0.00% Scars0.00%0.50%0.80%2.50% None26.60%15.00%0.00%17.30% Hepatitis0.00% 19.80%0.00% HIV / AIDS0.00% 16.00%0.00% Don’t know29.80%41.75%1.60%22.80%

Patients Satisfaction with Injection Therapy

Disposal of Syringes and Needle by HCPs Before AdvocacyAfter Advocacy Intervention n=500 Control n=400 Intervention n=500 Control n=400 Cut with needle cutter 2.60%3.20%72.60%6.30% Thrown in waste bin 77.00%78.00%24.60%76.80% Needle removed 0.40%0.50%0.60%5.50% Others 19.80%18.00%2.00%10.80% None 0.20%0.30%0.20%0.60%

Summary 1. Injection Therapy is very common for patients visiting private practitioners. 76 – 84% patients receive injections during a visit to HCPs. 2. Nearly 93 – 98% patients said that injection therapy was advised by HCPs. 3. Advocacy was done in from of Focus Group Discussions with patients, Interactive Group Discussions (IGDs) with prescribers and patients and distribution of IEC Material. 4. A 36% reduction in injection therapy was seen in the intervention group (51%) after advocacy as compared to the Control Group (84%). 5. New and packed syringes were used for injections in 92% patients in the intervention and 64.7% in the control group. 6. However, in only 55.6% patients in the control group, the packed syringe was opened in front of the patient as opposed to 89% in the intervention group (p < 0.05) 7. Early recovery was cited as the main reason for preference of injection therapy (91 – 97% patients ). Post health education only 74% patients felt early recovery was the main advantage of injections. 8. Prior to health education patients did not associate Hepatitis and HIV/AIDs with unsafe injections. Nearly 20% patients after advocacy could relate HIV/AIDs and Hepatitis with unsafe injection.

Conclusion And Recommendations 1) Interactive Group Discussions (IGDs) provide an opportunity for patients and HCPs to exchange views on injection overuse and clarify perceptions of both HCPs and patients. 2) IEC Material was effective in improving patient’s knowledge about hazards of unsafe injections. 3) Patients do not associate unsafe injections with the hazards of HIV/AIDs and Hepatitis. 4) HCPs need to spend more time providing health education to patients. 5) Both the Media and the Health Community need to educate patients on hazards of injection overuse. 6) Sharp waste disposal is of low priority amongst HCPs and more efforts need to be directed towards this. 7) Introduction of syringes with re-use prevention needs to be evaluated to further improve safe injection practices. 8) The SIGN Network should intensify efforts in developing countries and target patients to increase consumer demand for safe injections.

Acknowledgements This study was supported by the Safe Injection Global Network (SIGN), World Health Organization (WHO), Geneva.